Skip to content
Fiscal Receipts

Senate LDA lobbying filing

CENCORA, INC.

Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP Year: 2024 Period: Second Quarter Type: Q2

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities2

  • Health IssuesHCR

    IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).

  • PharmacyPHA

    Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.

Lobbyists8

  • ADAM STEINMETZ
  • ANDREW USYK
  • ANDREW USYKrevolving door

    Leg Assistant, Sen. Robert Casey; Legislative Aide, Sen. Kristen Gillibrand; Legislative Correspondent, Sen. Kristen Gillibrand; Compliance Officer, Sen. Gillibrand; Intern, Sen. Gillibrand and Rep. John Dingell

  • DEEMA TARAZI
  • EMILY FELDER
  • LAUREN MISH
  • WILLIAM DUNHAMrevolving door

    Dep CoS Policy-Ldr Kevin McCarthy; Policy Dir-McCarthy; Exec Dir-R Study Comm; Sr Policy Advisor-R Study Comm; Sr Leg. Asst-Rep Tom McClintock; Leg Asst-Rep Tom McClintock; Leg Cor-Rep Tom McClintock

  • ZACHARY PFISTER

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.